Related Experiment Video
Updated: Jun 6, 2026

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
Removal of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinase
Ben C L van Schaijk1, Martijn W Vos, Chris J Janse
1Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. B.VanSchaijk@mmb.umcn.nl
Abstract:
Genetically-modified mutants are now indispensable Plasmodium gene-function reagents, which are also being pursued as genetically attenuated parasite vaccines. Currently, the generation of transgenic malaria-parasites requires the use of drug-resistance markers. Here we present the development of an FRT/FLP-recombinase system that enables the generation of transgenic parasites free of resistance genes. We demonstrate in the human malaria parasite, P. falciparum, the complete and efficient removal of the introduced resistance gene. We targeted two neighbouring genes, p52 and p36, using a construct that has a selectable marker cassette flanked by FRT-sequences. This permitted the subsequent removal of the selectable marker cassette by transient transfection of a plasmid that expressed a 37°C thermostable and enhanced FLP-recombinase. This method of removing heterologous DNA sequences from the genome opens up new possibilities in Plasmodium research to sequentially target multiple genes and for using genetically-modified parasites as live, attenuated malaria vaccines.
Insights
Researchers developed a new system to create genetically modified malaria parasites without drug-resistance genes. This advancement aids Plasmodium research and the development of live, attenuated malaria vaccines.
Area of Science:
- Molecular Biology
- Parasitology
- Vaccine Development
Background:
- Genetically modified Plasmodium parasites are crucial for gene-function studies and are explored as live attenuated vaccines.
- Current methods for generating transgenic malaria parasites rely on drug-resistance markers, limiting further genetic manipulation.
Purpose of the Study:
- To develop a novel method for generating transgenic malaria parasites that are free of drug-resistance genes.
- To enable efficient removal of selectable markers from the Plasmodium falciparum genome.
Main Methods:
- Development and implementation of an Flp-recombinase (FLP) recognition target (FRT) system for marker removal.
- Targeting two neighboring genes (p52 and p36) using a construct with an FRT-flanked selectable marker cassette.
- Transient transfection with a plasmid expressing a thermostable enhanced FLP-recombinase for marker excision.
Main Results:
- Demonstrated complete and efficient removal of the introduced drug-resistance gene in Plasmodium falciparum.
- Successfully utilized the FRT/FLP system to excise the selectable marker cassette.
- Established a method for generating genetically modified parasites devoid of resistance markers.
Conclusions:
- The FRT/FLP system provides a powerful tool for generating marker-free transgenic Plasmodium parasites.
- This method facilitates sequential gene targeting and the development of genetically modified parasites for live attenuated malaria vaccines.
- Opens new avenues for Plasmodium research and vaccine development by enabling cleaner genetic modifications.
More Related Videos
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
10:35Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis
Published on: January 30, 2020